Consensus Guidelines on Therapeutic Monitoring of Vancomycin
May 7, 2020
Dr. Michael Rybak and Dr. Jennifer Le discuss with William Zellmer, Contributing Editor for AJHP, and Anna Dopp, Senior Director, Clinical Guidelines and Quality Improvement, the new consensus guidelines on the therapeutic monitoring of vancomycin for serious methicillin-resistant infections. The revised guidelines were approved by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. The ASHP Report under discussion will appear in the June 1, 2020, issue of AJHP.
SPEAKERS
- Michael J Rybak, PharmD, MPH, PhD, FCCP, FIDP, FIDSA
- Jennifer Le, PharmD, MAS, FIDSA, FCCP, FCSHP, BCPS-AQ ID
ADVERTISEMENT
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.